• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在精准医疗时代,提高生活质量仍然是最终目标:以肺癌为例。

Maximizing quality of life remains an ultimate goal in the era of precision medicine: exemplified by lung cancer.

作者信息

Yang Ping

机构信息

Mayo Clinic College of Medicine and Science, Mayo Clinic Arizona, 13400 E. Shea Boulevard, Scottsdale, AZ, USA.

出版信息

Precis Clin Med. 2019 Mar;2(1):8-12. doi: 10.1093/pcmedi/pbz001. Epub 2019 Mar 11.

DOI:10.1093/pcmedi/pbz001
PMID:35694702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8985777/
Abstract

An ultimate goal of precision medicine in lung cancer treatment is to restore patient health with maximized quality of life (QOL). Results from Mayo Clinic studies show that a significant improvement in fatigue, dyspnea, and pain scales could lead to better overall QOL. Although treatments and guidelines for clinical implementation to alleviate these key symptoms are available, few cancer patients receive adequate therapy, mostly because of limitations in current care delivery systems and unclear clinicians' roles. For optimal care of lung cancer survivors in different subpopulations, three barriers must be overcome: physicians' lack of knowledge, unwarranted practice variation, and uncertainty regarding care provider roles. Appropriate culturally adapted, tested and validated tools for QOL measures must be developed, rather than directly translating existing tools between different languages and across cultures or diverse subpopulations. Finally, lack of sensitive, adequate, and relevant tools in measuring health-related QOL (HRQOL) has long been an issue for effective data collection, demanding a global consensus on a set of core components that reflect the needs of all critical parties for the best cure and care, supporting patients to achieve optimal HRQOL.

摘要

肺癌治疗中精准医疗的最终目标是以最大化的生活质量(QOL)恢复患者健康。梅奥诊所的研究结果表明,疲劳、呼吸困难和疼痛量表的显著改善可带来更好的整体生活质量。尽管有缓解这些关键症状的治疗方法和临床实施指南,但很少有癌症患者得到充分治疗,主要原因是当前护理提供系统存在局限性以及临床医生的角色不明确。为了对不同亚群体的肺癌幸存者进行最佳护理,必须克服三个障碍:医生知识的缺乏、不必要的实践差异以及护理提供者角色的不确定性。必须开发经过文化适应、测试和验证的适当生活质量测量工具,而不是直接在不同语言、不同文化或不同亚群体之间翻译现有工具。最后,长期以来,缺乏敏感、充分和相关的工具来测量健康相关生活质量(HRQOL)一直是有效数据收集的一个问题,这需要就一组核心组成部分达成全球共识,这些核心组成部分反映了所有关键方对最佳治疗和护理的需求,支持患者实现最佳的健康相关生活质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f669/8985777/1a5a165805dc/pbz001f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f669/8985777/1a5a165805dc/pbz001f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f669/8985777/1a5a165805dc/pbz001f01.jpg

相似文献

1
Maximizing quality of life remains an ultimate goal in the era of precision medicine: exemplified by lung cancer.在精准医疗时代,提高生活质量仍然是最终目标:以肺癌为例。
Precis Clin Med. 2019 Mar;2(1):8-12. doi: 10.1093/pcmedi/pbz001. Epub 2019 Mar 11.
2
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.日本作为超老龄化社会的领跑者:来自日本医学与医疗护理的视角
Geriatr Gerontol Int. 2015 Jun;15(6):673-87. doi: 10.1111/ggi.12450. Epub 2015 Feb 5.
4
Sepsis Care Pathway 2019.2019年脓毒症护理路径
Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019.
5
Mapping unmet supportive care needs, quality-of-life perceptions and current symptoms in cancer survivors across the Asia-Pacific region: results from the International STEP Study.在亚太地区癌症幸存者中描绘未满足的支持性护理需求、生活质量认知和当前症状:来自国际 STEP 研究的结果。
Ann Oncol. 2017 Oct 1;28(10):2552-2558. doi: 10.1093/annonc/mdx350.
6
Telephone interventions for symptom management in adults with cancer.针对成年癌症患者症状管理的电话干预措施。
Cochrane Database Syst Rev. 2020 Jun 2;6(6):CD007568. doi: 10.1002/14651858.CD007568.pub2.
7
Quality of Life in NSCLC Survivors - A Multicenter Cross-Sectional Study.非小细胞肺癌幸存者的生活质量:一项多中心横断面研究。
J Thorac Oncol. 2019 Mar;14(3):420-435. doi: 10.1016/j.jtho.2018.11.019. Epub 2018 Nov 30.
8
Measurement of dyspnea and quality of life in advanced lung disease.晚期肺部疾病中呼吸困难及生活质量的测量
Clin Chest Med. 1997 Sep;18(3):457-69. doi: 10.1016/s0272-5231(05)70394-4.
9
Quality of life and symptom burden among long-term lung cancer survivors.长期肺癌幸存者的生活质量和症状负担。
J Thorac Oncol. 2012 Jan;7(1):64-70. doi: 10.1097/JTO.0b013e3182397b3e.
10
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.综合护理路径在医疗环境中对成人和儿童的有效性:一项系统评价。
JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001.

引用本文的文献

1
Editorial: Application of plant secondary metabolites to pain neuromodulation, volume III.社论:植物次生代谢产物在疼痛神经调节中的应用,第三卷。
Front Pharmacol. 2023 Feb 21;14:1166272. doi: 10.3389/fphar.2023.1166272. eCollection 2023.
2
Final Overall Survival, Safety, and Quality of Life Results From a Phase 2 Study of Crizotinib in East Asian Patients With -Positive Advanced NSCLC.克唑替尼用于东亚ALK阳性晚期非小细胞肺癌患者的2期研究的最终总生存期、安全性及生活质量结果
JTO Clin Res Rep. 2022 Sep 9;3(10):100406. doi: 10.1016/j.jtocrr.2022.100406. eCollection 2022 Oct.
3
Editorial: Application of plant secondary metabolites to pain neuromodulation, volume II.

本文引用的文献

1
Learning from Patients: Reflections on Use of Patient-Reported Outcomes in Lung Cancer Trials.向患者学习:关于肺癌试验中使用患者报告结局的思考
J Thorac Oncol. 2018 Dec;13(12):1815-1817. doi: 10.1016/j.jtho.2018.09.003. Epub 2018 Oct 15.
2
Amenorrhea after lung cancer treatment.肺癌治疗后的闭经。
Menopause. 2019 Mar;26(3):306-310. doi: 10.1097/GME.0000000000001199.
3
From evidence-based medicine to personalized medicine, with particular emphasis on drug-safety monitoring.从循证医学到个性化医学,尤其强调药物安全监测。
社论:植物次生代谢产物在疼痛神经调节中的应用,第二卷。
Front Pharmacol. 2022 Sep 26;13:1013063. doi: 10.3389/fphar.2022.1013063. eCollection 2022.
4
A Clinical Decision Support System for the Prediction of Quality of Life in ALS.一种用于预测肌萎缩侧索硬化症患者生活质量的临床决策支持系统。
J Pers Med. 2022 Mar 10;12(3):435. doi: 10.3390/jpm12030435.
5
Treatment preferences for epidermal growth factor receptor mutation-positive non-small cell lung cancer with brain metastasis: a large-scale survey from Chinese oncologists.表皮生长因子受体突变阳性的非小细胞肺癌脑转移患者的治疗偏好:中国肿瘤学家的大规模调查
Ann Transl Med. 2022 Jan;10(2):41. doi: 10.21037/atm-21-6413.
6
Editorial: Application of Plant Secondary Metabolites to Pain Neuromodulation.社论:植物次生代谢产物在疼痛神经调节中的应用
Front Pharmacol. 2021 Jan 14;11:623399. doi: 10.3389/fphar.2020.623399. eCollection 2020.
7
Treatment- and immune-related adverse events of immune checkpoint inhibitors in advanced lung cancer.免疫检查点抑制剂治疗相关不良反应及免疫相关不良反应在晚期肺癌中的作用。
Biosci Rep. 2020 May 29;40(5). doi: 10.1042/BSR20192347.
Arch Cardiovasc Dis. 2017 Jun-Jul;110(6-7):413-419. doi: 10.1016/j.acvd.2017.01.011. Epub 2017 May 25.
4
Epidermal growth factor receptor (EGFR): A rising star in the era of precision medicine of lung cancer.表皮生长因子受体(EGFR):肺癌精准医学时代的一颗新星。
Oncotarget. 2017 Jul 25;8(30):50209-50220. doi: 10.18632/oncotarget.16854.
5
Emotional Problems, Quality of Life, and Symptom Burden in Patients With Lung Cancer.肺癌患者的情绪问题、生活质量和症状负担
Clin Lung Cancer. 2017 Sep;18(5):497-503. doi: 10.1016/j.cllc.2017.02.008. Epub 2017 Mar 2.
6
Chest wall resection for non-small cell lung cancer: A case-matched study of postoperative pulmonary function and quality of life.非小细胞肺癌胸壁切除术:术后肺功能和生活质量的病例对照研究。
Lung Cancer. 2017 Apr;106:37-41. doi: 10.1016/j.lungcan.2017.01.014. Epub 2017 Jan 29.
7
Regional Emphysema Score Predicting Overall Survival, Quality of Life, and Pulmonary Function Recovery in Early-Stage Lung Cancer Patients.区域肺气肿评分对早期肺癌患者总生存期、生活质量和肺功能恢复的预测作用
J Thorac Oncol. 2017 May;12(5):824-832. doi: 10.1016/j.jtho.2017.01.016. Epub 2017 Jan 23.
8
Targeting ALK: Precision Medicine Takes on Drug Resistance.靶向ALK:精准医学应对耐药性。
Cancer Discov. 2017 Feb;7(2):137-155. doi: 10.1158/2159-8290.CD-16-1123. Epub 2017 Jan 25.
9
Personalizing NSCLC therapy by characterizing tumors using TKI-PET and immuno-PET.通过使用TKI-PET和免疫PET对肿瘤进行特征分析来实现非小细胞肺癌(NSCLC)治疗的个体化。
Lung Cancer. 2017 May;107:1-13. doi: 10.1016/j.lungcan.2016.05.025. Epub 2016 May 31.
10
Improving Spiritual Well-Being in Patients with Lung Cancers.改善肺癌患者的精神健康状况。
J Pastoral Care Counsel. 2015 Sep;69(3):156-62. doi: 10.1177/1542305015602711.